Department of Genetics, Faculty of Biology, Sofia University "St. Kliment Ohridski", 8, Dragan Tzankov blvd., 1164, Sofia, Bulgaria.
Mol Biol Rep. 2012 May;39(5):6133-9. doi: 10.1007/s11033-011-1429-3. Epub 2011 Dec 28.
Some of the approaches for cloning PCR products obtained with conventional Taq-polymerases which do not involve modifications of the ends of the vector or the insert are based on the use of restriction enzymes which can generate 3' thymine single nucleotide overhangs, such as Eam1105I (AhdI). Due to the presence of Eam1105I restriction site within the β-lactamase gene, this is not achievable with a number of the most widely used cloning vectors descending from the pUC family, for which the selection is based on the ampicillin resistance. In this report we describe the construction of a vector for TA-cloning, based on the abolishment of the Eam1105I recognition site within the β-lactamase gene by site-directed mutagenesis, and the introduction of a stuffer flanked by Eam1105I target sites within the polylinker of the pBluescript SK+ plasmid.
一些克隆 PCR 产物的方法是基于使用限制酶的,这些限制酶可以在载体或插入物的末端产生 3'胸腺嘧啶单核苷酸突出,如 Eam1105I(AhdI)。由于β-内酰胺酶基因内存在 Eam1105I 限制位点,这在许多最广泛使用的克隆载体中是不可能实现的,这些载体来源于 pUC 家族,其选择是基于氨苄青霉素抗性。在本报告中,我们描述了一种基于定向突变消除β-内酰胺酶基因内 Eam1105I 识别位点,以及在 pBluescript SK+质粒多克隆位点内引入由 Eam1105I 靶位点侧翼的填充序列的 TA 克隆载体的构建。